Tasly Pharmaceutical Group's low P/E ratio may reflect limit...

Tasly Pharmaceutical Group's low P/E ratio may reflect limited future growth expectations. Shareholders accept this, acknowledging future earnings may not surprise positively. Unless conditions improve, this will continue to limit the share price.